Kardigan (KARD) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Kardigan (KARD) is Moderate Underperform.

The composite score behind that read is -0.45, weighing +0.08 of bullish evidence against -0.59 bearish.

Kardigan last closed at $14.31, +4.22% on the session.

Against the IVW growth benchmark the position is +5.68% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

34 graded predictions for KARD so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Kardigan is classified under Health Care / Pharmaceuticals, with a market capitalisation of $1.28B.

StockMap tracks Kardigan as the 58th largest of the 152 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 66 Moderate Underperform, 52 Neutral, 33 Strong Underperform and 1 Moderate Outperform.

On that composite Kardigan ranks 111th of 152 in the group, against a group median of -0.27.